Articaine

CHEMBL1093 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
284.4 g/mol
LogP
2.8
Phase
4

A local anesthetic belonging to the amide class that blocks sodium channels in nerve membranes, preventing pain signals from being transmitted to the brain. It is widely used in dental procedures and is noted for its ability to penetrate bone tissue effectively.

Khối lượng phân tử

284,3800 g/mol

LogP

2,80

TPSA

95,70 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Cơ chế tác dụng

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC

InChI

InChI=1S/C13H20N2O3S/c1-5-6-14-9(3)12(16)15-10-8(2)7-19-11(10)13(17)18-4/h7,9,14H,5-6H2,1-4H3,(H,15,16)

Molecular Formula

C13H20N2O3S

HBD / HBA

2 / 5

Liên kết có thể quay

7

Nguyên tử nặng

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A local anesthetic belonging to the amide class that blocks sodium channels in nerve membranes, preventing pain signals from being transmitted to the brain. It is widely used in dental procedures and is noted for its ability to penetrate bone tissue effectively.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Articaine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1093. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 32170. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.